Department of Obstetrics and Gynecology, the Institute for Healthcare Policy and Innovation, the Michigan National Clinician Scholars Program, and the Center for Value-Based Insurance Design, University of Michigan, Ann Arbor, Michigan; the Department of Health Care Policy, Harvard Medical School, and the Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; and the Department of Obstetrics and Gynecology, Division of General Obstetrics and Gynecology, University of South Florida, Tampa, Florida.
Corresponding author: Alex F. Peahl, MD, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109; email: [email protected].
Rebecca Gourevitch was supported by grant number T32HS000055 from the Agency for Healthcare Research and Quality. Michelle Moniz is supported by the Agency for Healthcare Research and Quality grant K08 HS025465. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.
Financial Disclosure Vanessa Dalton reported receiving payment for serving as an expert witness for Bayer. She is a contributing editor to Medical Letter. She has received past grant funding from the Agency for Healthcare Research and Quality, Blue Cross Blue Shield of Michigan Foundation, the National Institutes of Health, and the Arnold Foundation. Mark Fendrick reported receiving personal fees or equity interest from AbbVie, Inc, Amgen, Inc, Centivo, Community Oncology Association, Covered California, EmblemHealth, Exact Sciences Corp, Freedman Health System, GRAIL, Harvard University, Health and Wellness Innovations, Health at Scale Technologies, MedZed, Penguin Pay, Risalto Health, Sempre Health, the State of Minnesota, US Department of Defense, Virginia Center for Health Innovation, Wellth, and Zanzors. Fendrick also reported receiving research support from the Agency for Healthcare Research and Quality, Boehringer Ingelheim, Gary and Mary West Health Policy Center, National Pharmaceutical Council, Patient-Centered Outcomes Research Institute, Pharmaceutical Research and Manufacturers of America, Robert Wood Johnson Foundation, and the State of Michigan/Centers for Medicare & Medicaid Services, and reported serving as co-editor of the American Journal of Managed Care and being a member of the Medicare Evidence Development & Coverage Advisory Committee and V-BID Health, LLC, outside the submitted work. Neel Shah is supported by the Peterson Center on Healthcare, the Rx Foundation, the Yellow Chair Foundation, the Alex and Rita Hillman Foundation, the Harvard Risk Management Foundation, and Merck for Mothers. The other authors did not report any potential conflicts of interest.
The authors thank Sarah Block for her contributions to the submission of this manuscript. Ms. Block is employed by the University of Michigan and did not receive any additional compensation for her contributions.
Peer reviews and author correspondence are available at http://links.lww.com/AOG/B815.
